The Effect of Kiwi on Blood Pressure, Endothelial Function, Antioxidant Capacity and Gene Expression

NCT00948363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2017-06-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether the intake of kiwi fruits will reduce systolic and diastolic blood pressure compared to intake of apples. The investigators hypothesize that the increased intake lutein or other components in the kiwi fruit will enhance nitric oxide bioavailability and lead to vascular relaxation.

Conditions

Interventions

OTHER

Kiwi fruits

Daily intake of 3 kiwi fruits for 8 weeks

OTHER

Apple

Daily intake of 1 apple (equivalent in energy) for 8 weeks

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER
  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Serena Tonstad, Professor · Preventive Cardiology, Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00948363 on ClinicalTrials.gov